Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GGPS1 | O95749 | 3/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.32 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.32 |
| ▸ | DNM1 | Q05193 | 5/20 | 0.32 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.31 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.31 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12663272 | 0.93 | PLA2G1B (0.39) | GGPS1LMNAPLA2G1BPLA2G2ADNM1 | |
| SCHEMBL24849421 | 0.91 | PLA2G1B (0.42) | GGPS1LMNAPLA2G1BPLA2G2ADNM1 | |
| SCHEMBL19752131 | 0.91 | GGPS1 (0.40) | GGPS1LMNAPLA2G1BPLA2G2ADNM1 | |
| SCHEMBL5949041 | 0.88 | LMNA (0.38) | GGPS1LMNAPLA2G1BPLA2G2ADNM1 | |
| SCHEMBL29306455 | 0.87 | LMNA (0.41) | GGPS1LMNAPLA2G1BPLA2G2ADNM1 | |
| SCHEMBL21143018 | 0.87 | GGPS1 (0.50) | GGPS1LMNAPLA2G1BPLA2G2ADNM1 | |
| SCHEMBL19293362 | 0.86 | TSHR (0.40) | GGPS1PIK3CD | |
| SCHEMBL19264421 | 0.85 | GGPS1 (0.44) | GGPS1DNM1 | |
| SCHEMBL5949352 | 0.84 | LMNA (0.35) | LMNAPLA2G1BPLA2G2ADNM1ACE2 | |
| SCHEMBL20032034 | 0.84 | OPRM1 (0.45) | GGPS1PLA2G1BPLA2G2AOPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4241772-A2 | PROCESS FOR THE PREPARATION OF COMPOUNDS USEFUL FOR TREATING SPINAL MUSCULAR ATROPHY | F. Hoffmann-La Roche AG (CH) | 2023-09-13 | — | — | EP | disclosed |
| US-9593243-B2 | Compound, pigment dispersing agent, pigment composition, pigment dispersion and toner containing said compound | CANON KABUSHIKI KAISHA (JP) | 2017-03-14 | — | — | US | disclosed |
| EP-1648446-B1 | INDOL-4 SULFONAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE 5-HT-6 AS MODULATORS | ESTEVE LABOR DR (ES) | 2009-06-03 | — | — | EP | disclosed |